melanotan-2 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-03-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Regulatory status differs by country, and in many places supplying the compound for human consumption is unlawful. Vendors frequently label material as intended for research use only, a designation that shifts stated purpose but does not create a legal pathway for personal use. Certificates of analysis accompanying such products vary widely in detail and provenance. Third-party testing exists but is voluntary, and results are rarely linked to a specific lot in a publicly verifiable way.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Melanotan II; MT-II; N-acetyl-norleucyl-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] amide | Naming follows peptide convention; the numeral distinguishes it from melanotan-1 |
| Molecular formula | C50H69N15O9 | Includes the lactam bridge; no counter-ion assumed |
| Monoisotopic mass | 1023.53 Da | Free base; salts and counter-ions shift the observed value |
| Appearance | White to off-white lyophilised powder | Batch-to-batch colour variation is not itself proof of impurity |
| Typical analytical method | RP-HPLC purity determination with ESI-MS identity confirmation | Retention time alone does not establish sequence identity |
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
electrochemistry A branch of physical chemistry concerned with the relationship between electrical potential difference and identifiable chemical change, as understood through either the chemical reactions accompanying the passage of an electric current or the potential difference that results from a particular chemical reaction.
England and Wales Vicki Jane Brown, Advanced Clinical Practitioner, Critical Care, South Western Ambulance Service. Cathy-Anne Miranda Burchett, Associate Director, Ambulance Operations, London Ambulance Service. Gail Wendy Herbert, Assistant Director, Quality Nursing and Patient Experience, Welsh Ambulance Service. Louise Victoria Walker, Ambulance Education, Training & Engagement Lead, Isle of Wight NHS Trust. Scotland Alistair MacDonald, Ambulance Care Assistant, Scottish Ambulance Service.
== Importance == Proteomic profiling is important in the advancement of our understanding of biological processes and mechanisms of disease. It helps in pathogen identification, thereby enhancing diagnostics and vaccine development by revealing protein interactions and functions related to virulence. Protein profiling has greatly helped in the early detection of cancers by using specific proteins found in the blood plasma. Recent studies have developed proteome-based tests with a high degree of accuracy in the detection of early stage cancers, using panels of proteins that distinguish cancerous from normal samples. For example, it has recently been demonstrated that using panels of ten sex-specific proteins, early-stage cancer could be identified with up to 93% accuracy in males and 84% in females at high specificity levels.
the mean infective period) of infectives are leaving this class per unit time to enter the removed class. These processes which occur simultaneously are referred to as the Law of Mass Action, a widely accepted idea that the rate of contact between two groups in a population is proportional to the size of each of the groups concerned. Finally, it is assumed that the rate of infection and recovery is much faster than the time scale of births and deaths and therefore, these factors are ignored in this model.
== Further reading == Kleerebezem M, Boekhorst J, van Kranenburg R, et al. (February 2003). "Complete genome sequence of Lactobacillus plantarum WCFS1". Proceedings of the National Academy of Sciences of the United States of America. 100 (4): 1990–1995. Bibcode:2003PNAS..100.1990K. doi:10.1073/pnas.0337704100. JSTOR 3138472. PMC 149946. PMID 12566566.
Sources: en.wikipedia.org
Fissionable nuclides primarily split in interactions with fast neutrons, while fissile nuclides easily split in interactions with "slow" i.e. thermal neutrons, usually originating from moderation of fast neutrons. The ability of three isotopes (U-233, U-235, and Pu-239) to sustain a nuclear chain reaction allows nuclear power plants to operate in a delayed critical state for a controllable energy release, and also for nuclear weapons to operate at a prompt supercritical state for an uncontrolled energy release occurring in about a microsecond. Fission is a form of nuclear transmutation because the resulting fragments (or daughter atoms) are not the same element as the original parent atom. The two (or more) nuclei produced are most often of comparable but slightly different sizes, typically with a mass ratio of products of about 3 to 2, for common fissile isotopes. Most fissions are binary fissions (producing two charged fragments), but occasionally (2 to 4 times per 1000 events), three positively charged fragments are produced, in a ternary fission. The smallest of these fragments in ternary processes ranges in size from a proton to an argon nucleus. The unpredictable composition of the products (which vary in a broad probabilistic and somewhat chaotic manner) distinguishes fission from purely quantum tunneling processes such as proton emission, alpha decay, and cluster decay, which give the same products each time.
Some patients may believe they have determined their own allergic sensitivity from observation. A skin test is much better than patient observation for allergy detection. If a serious life-threatening anaphylactic reaction has brought a patient in for evaluation, some allergists may prefer to perform an initial blood test before conducting a skin prick test. Skin testing may also not be possible in patients with widespread skin disease or those who have taken antihistamine within the past several days.
A titration curve for a diprotic acid contains two midpoints where pH=pKa. Since there are two different Ka values, the first midpoint occurs at pH=pKa1 and the second one occurs at pH=pKa2. Each segment of the curve that contains a midpoint at its center is called the buffer region. Because the buffer regions consist of the acid and its conjugate base, it can resist pH changes when base is added until the next equivalent points.
Anthony Tiran Todd (December 4, 1954 – November 6, 2024) was an American actor. Known for his distinctly deep and gravelly voice, he amassed numerous credits on screen and in video games since the 1980s, including the title character in the Candyman film series (1992–2021) and William Bludworth in the Final Destination franchise (2000–2025). For the former, he was nominated at the Critics' Choice and Fangoria Chainsaw Awards. Todd's films include Platoon (1986), Night of the Living Dead (1990), The Crow (1994), The Rock (1996), Wishmaster (1997), Hatchet, Minotaur (both 2006), The Man from Earth (2007), Frankenstein (2015), Death House (2017), and Hell Fest (2018). On television, he played Kurn in Star Trek: The Next Generation (1990–1991) and Star Trek: Deep Space Nine (1996), Lord Haikon on Stargate SG-1 (2005–2006), and appeared in the MTV series Scream (2019) and Devil May Cry (2025). Todd was a prolific voice actor, notably voicing the Vortigaunts in the Half-Life series of games, the Fallen in Michael Bay's Transformers: Revenge of the Fallen (2009), Zoom in The Flash (2014–2023), Darkseid in the DC Animated Movie Universe (2015–2020), Venom in the video game Marvel's Spider-Man 2 (2023), and Locus in the video game Indiana Jones and the Great Circle (2024). For Spider-Man 2, he received a British Academy Games Award nomination.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.
The natural hormone is a linear tridecapeptide that is rapidly degraded in circulation. Melanotan-2 is shortened, cyclised, N-terminally acetylated, and carries a D-amino acid substitution, all of which slow enzymatic breakdown.
No national medicines regulator has approved melanotan-2 for therapeutic or cosmetic use. In several jurisdictions it is treated as an unapproved prescription medicine, and its legal classification differs from country to country.
Dry powder is usually held frozen, shielded from light, and kept away from moisture. Desiccant packaging limits hydrolysis during storage. Solutions are typically aliquoted and frozen once, because repeated thawing shortens useful life.